| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |